Skip to content

Randomized Controlled Trial of Electroacupuncture for Residual Pain after Anterior Cervical Surgery

Electroacupuncture for Postoperative Pain After Anterior Cervical Spine Surgery for Cervical Spondylosis: A Clinical Observation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001551
Enrollment
Unknown
Registered
2026-06-20
Start date
2020-09-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior cervical spine surgery pain

Interventions

Treatment group:Electroacupuncture (acupoints: bilateral cervical Jiaji, GB20, GB21, GV14, LI11, SI3, TE5, LI4
dense-sparse wave, 20 Hz, 20-30 min/session, once daily, 6 days/course, 2 courses) combined with basic treatment (routine postoperative care). 2()
Control group:Manual acupuncture (same acupoints and course as treatment group, without electrical stimulation) combined with basic treatment.

Sponsors

The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age between 30 and 80 years, male or female; Pain localized to the neck and shoulder region only; Duration of preoperative neurological symptoms =2 years; Postoperative pain is reduced but not completely resolved compared to preoperative status; Number of surgical segments =2; No evidence of nerve root compression on postoperative imaging; No other diseases that may interfere with the treatment; No previous treatment for this condition before enrollment; No history of allergy to iodine-based disinfectants or needle phobia; Good compliance, willing to accept the treatment protocol and sign informed consent form.

Exclusion criteria

Exclusion criteria: Pain caused by other conditions such as adjacent segment herniation or peripheral neuropathy; Postoperative wound infection or systemic infection; Diagnosed with vertebral artery type or sympathetic type cervical spondylosis without surgical indications; Combined spinal injury with spinal cord injury; Spinal tuberculosis, spinal tumor, or developmental spinal stenosis; Severe cardiovascular, cerebrovascular or other major organ diseases; Skin ulceration or relevant skin diseases; Pregnancy, lactation, or physical weakness intolerable to the treatment; Currently receiving other therapies, participating in another clinical trial, or having participated in another clinical study within the past 3 months that may affect the evaluation of this study.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale;

Secondary

MeasureTime frame
Simplified McGill Pain Questionnaire Scoring;Current Pain Intensity Score;TANAKA MASATOSHI Cervical Symptoms Evaluation Scale Scoring;Neck Disability Index;Serum tumor necrosis factor-alpha level;Serum interleukin-6 level;

Countries

China

Contacts

Public ContactWuhong

The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

1215135426@qq.com19984488378

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026